MCAS the Invisible Fire: Why Your Antihistamines Aren't Enough

The latest research (2024–2026) on Mast Cell Activation Syndrome (MCAS) highlights a shift toward “personalized immunomodulation,” focusing on the interplay between the gut-brain-immune axis, the microbiome, and phytochemical “next-generation” mast cell stabilizers (Mihele et al., 2023; Vanuytsel et al., 2023).